Back to results
US 2004/0002507 A1Published application
Rho-kinase inhibitors
AssigneeBayer Aktiengesellschaft
InventorsDhanapalan Nagarathnam, Jacques Dumas, Holia Hatoum-Mokdad, Stephen Boyer, Hans Pluempe
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.
Claims5
A compound of the formula
- 84 85 86 87 88 89 90 91 92 93
Dependencies are inferred from the claim text.